Sun Pharma Share Price ₹1,880: Up 2.8% for the Week

SUNPHARMA closed at ₹1,880.00 on 13-11 (−0.3%). Over the week +2.8%, past month +6.2%, past year +11.5%.

SUNPHARMA's 52-week high is ₹2,046.90 and its 52-week low is ₹1,583.70. The 13-11 close of ₹1,880.00 is 63% of the way up that range and 8.2% below the 52-week high.

SUNPHARMA's P/E is 34.6x on 13-11 (P/B 5.0x), which is 0.93x its own 5-year median of 37x. A P/E on its own does not say what happens next.

As of the Sep 2026 quarter-end promoters hold 52.7% (down 1.8 points) of SUNPHARMA, FIIs 14.4% (−0.2 points), DIIs 22.3% (+0.2 points) and the public 10.7%. Promoter pledge: 0.01% of promoter shares (15-Oct-2026), −1.64 pts on the quarter.

Nearest resistance zone: ₹1,967.73–₹1,984.80 (4.7% above the 13-11 close, tested 0× before). Nearest support zone: ₹1,583.70–₹1,602.48 (14.8% below the 13-11 close, tested 1× before). These are prices where the stock has stalled or turned before, not forecasts.

Zonters does not give buy or sell recommendations, price targets, or personal advice. The facts on 13-11: SUNPHARMA is 63% of the way up its 52-week range and 8.2% below its 10-year high; P/E 0.93x its 5-year median; FIIs cut their holding by 0.2 points last quarter; delivery 53.0% against about 63% normal. For a decision, speak to a SEBI-registered investment adviser.

SUNPHARMA fell 0.3% to ₹1,880.00 on 13-11, on volume 0.9× its usual, with delivery at 53.0% (about 63% is normal). The Nifty moved −0.6% the same day. Its sector, Nifty PHARMA, ranks 3 of 18 on 6-month strength (leading). Zonters shows what the data did, not news or results.

SUNPHARMA's delivery was 53.0% on 13-11, 59.1% over the last complete week and 57.9% over the last complete month, against a 60-day normal of about 63%. Delivery is the share of traded shares taken into investors' accounts instead of being closed out the same day. Heavy-delivery days (date, price, delivery): 28-07-26 ₹1,976.70 (75.4%); 27-07-26 ₹1,973.70 (83.1%); 09-06-26 ₹1,779.00 (73.1%).

To 13-11: 1 month SUNPHARMA +6.2% vs Nifty +11.1% (gap 5.0 points behind); 3 months SUNPHARMA −3.3% vs Nifty +3.1% (gap 6.4 points behind); 1 year SUNPHARMA +11.5% vs Nifty −1.7% (gap 13.2 points ahead). Its sector, Nifty PHARMA, ranks 3 of 18 on 6-month strength (leading).

SUNPHARMA is 8.2% below its 10-year high on 13-11. Its worst fall of 10% or more in the 9 years of data (since 17-10-16) was 57% from 19-10-16 to 23-03-20, back at the old high on 30-07-21 (16 months after the low).